Location History:
- Milan, IT (2012)
- Rome, IT (2015)
Company Filing History:
2 out of 33 
2 out of 312 
1 out of 3 
Years Active: 2012-2015
Title: Claudia Verderio: Innovator in Neurological Research
Introduction
Claudia Verderio is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of neurological research, particularly in the area of biomarkers and therapeutic approaches for neurological disorders. With a total of two patents to her name, her work is paving the way for advancements in diagnostics and treatment.
Latest Patents
Claudia Verderio's latest patents include "Increase of myeloid microvesicles in the cerebrospinal fluid as biomarker of microglia/macrophage activation in neurological disorders." This invention relates to a method for diagnosing and prognosing neurological diseases characterized by inflammation. It involves measuring the amount of myeloid-derived microvesicles in cerebrospinal fluid samples from subjects. The invention also provides a method for predicting and monitoring the efficacy of treatments for neurological pathologies and disease progression. Another notable patent is "GPR17 modulators, method of screening and uses thereof." This invention offers GPR17 modulators and methods for screening and utilizing them in the diagnosis and therapy of diseases involving GPR17 activation, particularly in cases of ischemic brain damage.
Career Highlights
Claudia has worked with esteemed institutions such as Università degli Studi di Milano and Consiglio Nazionale delle Ricerche. Her research has focused on understanding the mechanisms underlying neurological disorders and developing innovative solutions to address these challenges.
Collaborations
Claudia has collaborated with notable colleagues, including Maria Pia Abbracchio and Paolo Ciana. These partnerships have enhanced her research and contributed to the advancement of knowledge in her field.
Conclusion
Claudia Verderio is a trailblazer in neurological research, with her patents reflecting her commitment to improving diagnostics and treatments for neurological disorders. Her work continues to inspire and drive innovation in the medical community.